Vaccine News and Research

Latest Vaccine News and Research

Government mistrust plays a vital role in slowing down child vaccination progress in Africa

Mistrust in local and national government plays a significant role in slowing down child vaccination progress in Africa - the continent home to half of the world's unvaccinated and under-vaccinated children, new research reveals.

30 Apr 2021

When can we stop wearing face masks?

Global rollout of vaccines to prevent coronavirus disease 2019 (COVID-19) is underway, with nine different vaccines approved for distribution by different countries. With four vaccines approved for distribution in the U.S., as of April 30, 2021, 29.9% of the U.S. population has now been fully vaccinated against SARS-CoV-2.

30 Apr 2021

Human to animal transmission of SARS-CoV-2 in households is common

Coronaviruses are seen in multiple mammalian species. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the COVID-19 pandemic, is said to have passed to humans from a mammalian source and to have originated from an animal reservoir as a zoonotic pathogen.

29 Apr 2021

Guidance on diagnosis and management of cerebral venous sinus thrombosis after a COVID-19 vaccine

Last Friday, the Centers for Disease Control and Prevention and the U.S. Food & Drug Administration lifted the pause in administration of the Johnson & Johnson (Janssen) COVID-19 vaccine in the U.S.

29 Apr 2021

Study: More than a quarter of American infants not received common childhood vaccines

More than a quarter of American infants in 2018 had not received common childhood vaccines that protect them from illnesses such as polio, tetanus, measles, mumps and chicken pox, new research from the University of Virginia School of Medicine reveals.

29 Apr 2021

A ‘dose of hope’? Fact-checking President Joe Biden’s first speech to Congress

In his first speech before Congress, President Joe Biden argued it was time to turn the coronavirus pandemic into a historic opportunity to expand government for the benefit of a wider range of Americans, urging investments in jobs, climate change, child care, infrastructure and more.

29 Apr 2021

Covid forces cohousing communities to examine shared values and relationships

Tensions were running high at PDX Commons, a cohousing community for adults 55 and older in Portland, Oregon. Several people wanted to keep visitors off-site until all 35 residents were vaccinated. Others wanted to open to family and friends for the first time in a year.

29 Apr 2021

COVID-19 vaccination willingness in Australia hinges on public perception of health threat

A new study reports the results of a survey in Australia on vaccine willingness at two points: the first wave in April 2020, and during November of the same year, when cases had dropped significantly.

29 Apr 2021

Researchers discover how SARS-CoV-2 hijacks human cell machinery to blunt immune response

Researchers at University of California San Diego School of Medicine have discovered one way in which SARS-CoV-2, the coronavirus that causes COVID-19, hijacks human cell machinery to blunt the immune response, allowing it to establish infection, replicate and cause disease.

29 Apr 2021

Study: Failure to combat second-dose vaccine attrition could prolong the pandemic

Though more than 131 million Americans have received at least one dose of COVID-19 vaccine to date, public confusion and uncertainty about the importance of second doses and continued public health precautions threaten to delay a U.S. return to normalcy, according to Cornell-led research published April 28 in the New England Journal of Medicine.

29 Apr 2021

Study of 180 breastfeeding mothers after mRNA COVID-19 vaccination

Vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, were developed at an unprecedented pace. To date, more than 1 billion vaccine doses have been administered worldwide, many of which messenger RNA (mRNA) based.

29 Apr 2021

Potent monoclonal antibody shows promise against emerging SARS-CoV-2 variants of concern

In a new study currently available on the bioRxiv* preprint server, a group of US-based researchers developed a panel of neutralizing monoclonal antibodies against SARS-CoV-2 that can block viral attachment to cells – and pinpointed a specific one that can potently neutralize all tested variants of concern.

28 Apr 2021

Safety and efficacy of Pfizer and AstraZeneca COVID-19 vaccines even better than clinical trials predicted

Researchers in the UK and United States have demonstrated the efficacy of one dose of either the Pfizer-BioNTech or Oxford-AstraZeneca vaccine against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a real-world community setting in the UK.

28 Apr 2021

Recovered COVID-19 patients show signs of long-term immunity

A study conducted by researchers in the United States has found that most patients who recovered from coronavirus disease 2019 (COVID-19) showed signs of long-lasting immunity against the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

28 Apr 2021

UH center seeks to investigate vaccine hesitancy in Houston's underserved communities

With COVID-19 vaccines more readily available than ever, there remains vaccine hesitancy in diverse communities across metropolitan Houston and beyond.

28 Apr 2021

Nanobodies may be the key to blocking tick-borne bacterial infection

Tiny molecules called nanobodies, which can be designed to mimic antibody structures and functions, may be the key to blocking a tick-borne bacterial infection that remains out of reach of almost all antibiotics, new research suggests.

28 Apr 2021

Study examines mRNA COVID-19 vaccine’s effectiveness across age and gender

The findings reveal that although the two-dose vaccine regimen initially induces robust antibody response in all age groups, older male individuals are particularly associated with a gradual decline in vaccine-induced immunity six weeks after the second vaccine dose.

28 Apr 2021

COVID-19 donor antibodies show broad cross-reactivity against SARS-CoV-2 variants and related viruses

A new study reports on a set of antibodies from COVID-19 donor serum, which seems to be cross-reactive across multiple Sarbecoviruses, including the very similar SARS-CoV-2, SARS-CoV and Middle East Respiratory Syndrome (MERS)-CoV.

28 Apr 2021

Albumedix extends research collaboration with Cobra Biologics to optimize viral vector manufacturing

Albumedix Ltd. ('Albumedix'), an emerging leader in the enablement of advanced therapies and recognized global leader in recombinant human albumin (rHA) has today announced an extension to its research collaboration with Cobra Biologics, the gene therapy division of Cognate BioServices, a Charles River Laboratories International, Inc. company.

From Albumedix Ltd. 28 Apr 2021

Peptide nucleocapsid vaccine candidate elicits protective T cell immunity against SARS-CoV-2 in vivo

A new study describes a synthetic peptide used as a platform to generate protective adaptive cellular immunity to the virus in rhesus macaques, which are the gold standard for preclinical testing in humans.

28 Apr 2021

Vaccine News and Research

Latest Vaccine News and Research

Government mistrust plays a vital role in slowing down child vaccination progress in Africa

When can we stop wearing face masks?

Human to animal transmission of SARS-CoV-2 in households is common

Guidance on diagnosis and management of cerebral venous sinus thrombosis after a COVID-19 vaccine

Study: More than a quarter of American infants not received common childhood vaccines

A ‘dose of hope’? Fact-checking President Joe Biden’s first speech to Congress

Covid forces cohousing communities to examine shared values and relationships

COVID-19 vaccination willingness in Australia hinges on public perception of health threat

Researchers discover how SARS-CoV-2 hijacks human cell machinery to blunt immune response

Study: Failure to combat second-dose vaccine attrition could prolong the pandemic

Study of 180 breastfeeding mothers after mRNA COVID-19 vaccination

Potent monoclonal antibody shows promise against emerging SARS-CoV-2 variants of concern

Safety and efficacy of Pfizer and AstraZeneca COVID-19 vaccines even better than clinical trials predicted

Recovered COVID-19 patients show signs of long-term immunity

UH center seeks to investigate vaccine hesitancy in Houston's underserved communities

Nanobodies may be the key to blocking tick-borne bacterial infection

Study examines mRNA COVID-19 vaccine’s effectiveness across age and gender

COVID-19 donor antibodies show broad cross-reactivity against SARS-CoV-2 variants and related viruses

Albumedix extends research collaboration with Cobra Biologics to optimize viral vector manufacturing

Peptide nucleocapsid vaccine candidate elicits protective T cell immunity against SARS-CoV-2 in vivo

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in